Patient Advocacy
-
Perioperative Nivolumab Proves Safe, Effective for Patients with Resectable Early-Stage NSCLC
Dr. Jonathan Spicer shared patient-reported outcomes data from CheckMate 77T showing the regimen is both safe and tolerable for patients.
-
Patient Perspective: Copay Accumulators Create Yet Another Cost Burden Faced by US Patients in Treatment with Targeted Therapies
Advocate and best-selling author Annabelle Gurwitch shines light on pharmacy benefit practices that cost patients thousands while increasing profits for insurance companies.
-
Falling Through the Cracks: Battling Barriers in Lung Cancer Care
California firefighter Daiyo Ito says that while the Los Angeles County wildfires brought increased health risks for his mother, the biggest obstacle to her care and treatment was navigating her lung cancer diagnosis within a broken healthcare system.
-
Up in the Air: A Patient’s Perspective on Navigating Lung Cancer Treatment During One of the Most Devastating Wildfires in US History
Lynn Lieberman was already in a fight against lung cancer, but she faced a second battle when the Los Angeles wildfires spread throughout her community.
-
From Grief to Global Change: How the STARS Program Empowers Advocates to Drive Lung Cancer Research
Discover how to turn your personal experience with lung cancer into meaningful change with the IASLC STARS program.
-
Picking Up the Pieces: The Impact of the Western US Wildfires on Cancer Care
Dr. Karen Reckamp discusses the challenges that both patients and oncologists in the Los Angeles area experienced during the devastating fires.
-
Palliative Care: A Path to Living Well with Advanced Cancer
Patient Advocates Angus Pratt and Terri Ann DiJulio explore the key role that the medical community plays in helping patients and families understand the importance of palliative care.
-
Breaking the Silence: The #HearHer Campaign for Women with Lung Cancer
Narjust Florez, MD, and Angela Morabito, BS, launched the #HearHer campaign to raise awareness about the increasing incidence of lung cancer among women and the frequent delays in diagnosis.
-
Strength in Numbers: Researchers and Advocacy Groups Unite to Decode the Impact of Genetics on Lung Cancer Risk
A new genetics study aims to collect data from 10,000 participants diagnosed with lung cancer to improve future outcomes and enhance research.
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Heidi Nafman-Onda, founder of The White Ribbon Project, shares her experience discovering and grappling with the long-term effects of radiation therapy and addresses the need for coordinated survivorship care.
View ILCN Archives
Provider Resources